代谢综合征与COVID-19死亡率在New Orleans成年黑人患者中的关联
研究纳入2020年3月30日至4月5日New Orleans两家医院连续住院的287例COVID-19患者,按WHO标准定义代谢综合征(MetS),66%存在MetS。MetS与死亡率、ICU需求、有创机械通气和ARDS的调整比值比均显著升高相关,而高血压、肥胖、糖尿病单独分析时与死亡率无显著关联。
要点
- 在287例住院COVID-19患者中,66%存在MetS,MetS与死亡率升高相关(aOR 3.42)。
- MetS还与ICU需求(aOR 4.59)、有创机械通气(aOR 4.71)和ARDS(aOR 4.70)相关。
- 高血压、肥胖、糖尿病单独分析时与死亡率无显著关联。
核心结论
- 在主要为黑人住院COVID-19患者中,高血压、肥胖和糖尿病聚集为MetS较这些合并症单独存在时增加死亡 odds。
研究设计与样本
- 研究纳入2020年3月30日至4月5日New Orleans两家医院连续住院的287例COVID-19患者,MetS按世界卫生组织标准定义。
主要发现
- 287例患者平均年龄61.5岁,女性56.8%,非西班牙裔黑人85.4%,MetS存在于188例(66%)。
- MetS与非MetS相比,死亡率aOR 3.42(95% CI 1.52-7.69),ICU需求aOR 4.59(95% CI 2.53-8.32),有创机械通气aOR 4.71(95% CI 2.50-8.87),ARDS aOR 4.70(95% CI 2.25-9.82)。
- 高血压、肥胖和糖尿病单独多变量分析显示与死亡率无关联。
- 肥胖与ICU(aOR 2.18 [95% CI 1.25-3.81])、ARDS(aOR 2.44 [95% CI 1.28-4.65])和有创机械通气(aOR 2.36 [95% CI 1.33-4.21])相关;糖尿病与ICU(aOR 2.22 [95% CI 1.24-3.98])和有创机械通气(aOR 2.12 [95% CI 1.16-3.89])相关;高血压与任何结局均无显著关联。
- 与MetS相关的炎症标志物CRP和LDH与死亡率相关:CRP aOR 3.66(95% CI 1.22-10.97),LDH aOR 3.49(95% CI 1.78-6.83)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Coronavirus disease 2019 (COVID-19) mortality is high in patients with hypertension, obesity, and diabetes. We examined the association between hypertension, obesity, and diabetes, individually and clustered as metabolic syndrome (MetS), and COVID-19 outcomes in patients hospitalized in New Orleans during the peak of the outbreak. RESEARCH DESIGN AND METHODS: Data were collected from 287 consecutive patients with COVID-19 hospitalized at two hospitals in New Orleans, LA, from 30 March to 5 April 2020. MetS was identified per World Health Organization criteria. RESULTS: Among 287 patients (mean age 61.5 years; female, 56.8%; non-Hispanic Black, 85.4%), MetS was present in 188 (66%). MetS was significantly associated with mortality (adjusted odds ratio [aOR] 3.42 [95% CI 1.52-7.69]), intensive care unit requirement (ICU) (aOR 4.59 [CI 2.53-8.32]), invasive mechanical ventilation (IMV) (aOR 4.71 [95% CI 2.50-8.87]), and acute respiratory distress syndrome (ARDS) (aOR 4.70 [95% CI 2.25-9.82]) compared with non-MetS. Multivariable analyses of hypertension, obesity, and diabetes individually showed no association with mortality. Obesity was associated with ICU (aOR 2.18 [95% CI 1.25-3.81]), ARDS (aOR 2.44 [95% CI 1.28-4.65]), and IMV (aOR 2.36 [95% CI 1.33-4.21]). Diabetes was associated with ICU (aOR 2.22 [95% CI 1.24-3.98]) and IMV (aOR 2.12 [95% CI 1.16-3.89]). Hypertension was not significantly associated with any outcome. Inflammatory biomarkers associated with MetS, CRP and lactate dehydrogenase (LDH), were associated with mortality (CRP [aOR 3.66] [95% CI 1.22-10.97] and LDH [aOR 3.49] [95% CI 1.78-6.83]). CONCLUSIONS: In predominantly Black patients hospitalized for COVID-19, the clustering of hypertension, obesity, and diabetes as MetS increased the odds of mortality compared with these comorbidities individually.
引用
- Xie J, Zu Y, Alkhatib A, et al. Metabolic Syndrome and COVID-19 Mortality Among Adult Black Patients in New Orleans. Diabetes Care. 2021. PMID: 32843337. doi:10.2337/dc20-1714
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。